ArticleStatistics in medicine2026
Optimizing Treatment Decision Estimation for Right-Censored Survival Data Through Parameter Transfer Learning.
Article in Statistics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Accurately estimating treatment effects is crucial for designing optimal treatment plans in personalized medicine, especially in the presence of right-censored survival data. We propose a parameter transfer learning method for estimating treatment effects on right-censored survival data, which leverages multi-source auxiliary data to enhance the prediction accuracy and robustness of the target model. This method constructs multiple source models by extracting shared parameters from other datasets and uses a smoothed concordance index function specifically designed for right-censored survival data to estimate candidate model parameters. To enhance performance, a leave-one-out cross-validation criterion is applied to optimize model averaging weights. Theoretically, we have demonstrated that under mild conditions, the proposed method asymptotically achieves the highest smoothed concordance index when the target model is misspecified, and ensures model weight consistency when the target model is correctly specified. Simulation studies confirm the advantages of our proposed method in reducing bias and enhancing prediction accuracy, particularly with right-censored and heterogeneous data. Its application to the SUPPORT (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) extension dataset, support2, further demonstrates its strong potential in personalized clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.